Position in IQV
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$418,707
+$30,388 QoQ
Shares Held
2,167
-4.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#681
of 1,077 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Equitable Holdings, Inc. holds $13,321,050 across 7 Diagnostics & Research names. IQV ranks #5 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
14,295 | $7,166,941 | |
| 2 | DHR |
Danaher Corp /De/
|
15,830 | $3,015,298 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
2,752 | $1,448,762 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
1,482 | $784,852 | |
| 5 | IQV |
Iqvia Holdings Inc.
This page
|
2,167 | $418,707 | |
| 6 | GH |
Guardant Health, Inc.
|
1,688 | $253,250 | |
| 7 | LH |
Labcorp Holdings Inc.
|
833 | $233,240 |
All Filings in IQV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $418,707 | 2,167 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $388,319 | 2,277 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $334,508 | 1,484 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $262,307 | 1,381 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $240,482 | 1,526 | Shares | Defined | 2025-08-15 | |
| 2024-12-31 | $217,340 | 1,106 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $268,013 | 1,131 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||